Search Results Search Sort by RelevanceMost Recent Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78 AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Jul 2017 How Should Clinicians Counsel a Woman with a Strong Family History of Early-Onset Alzheimer’s Disease about Her Pregnancy? Marianna V. Mapes, Barbara M. O'Brien, MD, and Louise P. King, MD, JD Pregnant women at high risk for heritable diseases need support and nondirective genetic counseling. AMA J Ethics. 2017;19(7):663-674. doi: 10.1001/journalofethics.2017.19.7.ecas4-1707. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Viewpoint Jan 2021 The Nazi Analogy Muddles Our Thinking About Physician Aid-in-Dying in the US Holland M. Kaplan, MD Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations. AMA J Ethics. 2021;23(1):E78-81. doi: 10.1001/amajethics.2021.78
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Jul 2017 How Should Clinicians Counsel a Woman with a Strong Family History of Early-Onset Alzheimer’s Disease about Her Pregnancy? Marianna V. Mapes, Barbara M. O'Brien, MD, and Louise P. King, MD, JD Pregnant women at high risk for heritable diseases need support and nondirective genetic counseling. AMA J Ethics. 2017;19(7):663-674. doi: 10.1001/journalofethics.2017.19.7.ecas4-1707.